                         SEQUENCE LISTING

<110>  CCAM biotherapeutics
 
<120>  COMPOSITIONS COMPRISING ANTIBODIES TO CEACAM-1 AND KIR FOR CANCER
        THERAPY

<130>  CCAM011 PCT

<160>  6     

<170>  PatentIn version 3.5

<210>  1
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide

<400>  1

Gly Tyr Ala Phe Thr Asn Asn Leu Ile Glu 
1               5                   10  


<210>  2
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide

<400>  2

Val Ile Asn Pro Gly Ser Gly Asp Thr Asn Tyr Asn Glu Lys Phe Lys 
1               5                   10                  15      


Gly 
    


<210>  3
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic sequence

<400>  3

Gly Asp Tyr Tyr Gly Gly Phe Ala Val Asp Tyr 
1               5                   10      


<210>  4
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide

<400>  4

Arg Thr Ser Gln Asp Ile Gly Asn Tyr Leu Asn 
1               5                   10      


<210>  5
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide

<400>  5

Tyr Thr Ser Arg Leu His Ser 
1               5           


<210>  6
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide

<400>  6

Gln Gln Gly Lys Ser Leu Pro Arg Thr 
1               5                   


